Education
About Us
Working with TipRanks
Follow Us
Yidu Tech, Inc. (HK:2158)
:2158
2158 Stock Chart & Stats
HK$5.58
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$5.58
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$4.65 - HK$8.35
Previous CloseN/A
Volume5.15M
Average Volume (3M)6.50M
Market Cap
HK$6.38B
Enterprise ValueHK$4.55B
Total Cash (Recent Filing)HK$2.26B
Total Debt (Recent Filing)HK$130.73M
Price to Earnings (P/E)―
Beta1.72
Next Earnings
Jul 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding1,072,517,100
10 Day Avg. Volume6,345,530
30 Day Avg. Volume6,499,248
Financial Highlights & Ratios
PEG Ratio1.23
Price to Book (P/B)1.55
Price to Sales (P/S)8.53
P/FCF Ratio-17.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$8.90Price Target Upside59.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet / Low LeverageVery low debt-to-equity (0.03) and an ~83.6% equity ratio give the company financial flexibility and a longer runway to invest in product development or weather revenue pressure without material refinancing risk, supporting durable operations over months.
Improving Free Cash Flow GenerationA notable increase in free cash flow and a positive free cash flow to net income ratio indicate the company can convert activities into cash despite accounting losses, which strengthens funding for R&D or strategic initiatives and reduces reliance on external capital.
Recurring Subscription And Licensing Revenue ModelA subscription and licensing business with healthcare and pharma customers creates recurring revenue, higher customer stickiness, and predictable renewal cycles. Strategic partnerships and funded R&D projects further diversify income and support steady demand over time.
Bears Say
Declining Revenue Growth And Negative MarginsRevenue contraction (-8.34%) combined with negative net profit and EBIT margins signals weakening core commercial performance. Persistently falling top-line and margin pressure undermine scalability and long-term profitability unless product adoption or pricing improves.
Negative Operating Cash FlowDespite improved free cash flow metrics, ongoing negative operating cash flow indicates core operations are not yet cash-generative. This structural shortfall increases reliance on financing or asset sales and constrains investment in growth initiatives.
Negative Return On Equity And Ongoing LossesA negative ROE driven by sustained losses implies shareholder capital is not earning returns and may lead to dilution or constrained capital access. Over time this limits ability to scale, attract investors, or reward shareholders absent a clear path to sustained profitability.
Yidu Tech, Inc. News
2158 FAQ
What was Yidu Tech, Inc.’s price range in the past 12 months?
Yidu Tech, Inc. lowest stock price was HK$4.65 and its highest was HK$8.35 in the past 12 months.
What is Yidu Tech, Inc.’s market cap?
Yidu Tech, Inc.’s market cap is HK$6.38B.
When is Yidu Tech, Inc.’s upcoming earnings report date?
Yidu Tech, Inc.’s upcoming earnings report date is Jul 01, 2026 which is in 129 days.
How were Yidu Tech, Inc.’s earnings last quarter?
Yidu Tech, Inc. released its earnings results on Nov 27, 2025. The company reported -HK$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.011.
Is Yidu Tech, Inc. overvalued?
According to Wall Street analysts Yidu Tech, Inc.’s price is currently Undervalued.
Does Yidu Tech, Inc. pay dividends?
Yidu Tech, Inc. does not currently pay dividends.
What is Yidu Tech, Inc.’s EPS estimate?
Yidu Tech, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yidu Tech, Inc. have?
Yidu Tech, Inc. has 1,072,517,100 shares outstanding.
What happened to Yidu Tech, Inc.’s price movement after its last earnings report?
Yidu Tech, Inc. reported an EPS of -HK$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.373%.
Which hedge fund is a major shareholder of Yidu Tech, Inc.?
Currently, no hedge funds are holding shares in HK:2158
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Yidu Tech, Inc. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-2.55%
12-Months-Change
Fundamentals
Return on Equity
-2.23%
Trailing 12-Months
Asset Growth
-1.48%
Trailing 12-Months
Company Description
Yidu Tech, Inc.
Yidu Tech, Inc. is a leading healthcare technology company based in China, specializing in providing data-driven solutions for the healthcare sector. The company integrates artificial intelligence and big data analytics to enhance the efficiency and quality of healthcare delivery. Yidu Tech's core products include medical data platforms, AI-driven diagnostic tools, and healthcare management systems, which cater to hospitals, healthcare providers, and pharmaceutical companies.
2158 Stock 12 Month Forecast
Average Price Target
HK$8.90
▲(59.50% Upside)
Technical Analysis
China Isotope & Radiation Corp.
―
Mediwelcome Healthcare Management & Technology Inc.
―
Beijing Airdoc Technology Co. Ltd. Class H
―
CStone Pharmaceuticals
―
China Shineway Pharmaceutical Group Limited
―
Options Prices
Currently, No data available
---